SEC Form 4 · accession 0001547522-17-000016
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bobbi Jo Brockmann
Officer — VP of Sales & Marketing
Period of report
Feb 10, 2017
Accepted (ET)
Feb 14, 2017 · 12:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to buy) | $7.54 | Dec 16, 2015 | A | 10,000 | A | Dec 16, 2018 | Dec 15, 2025 | Common Stock | 10,000 | 10,000 | D |
| Incentive Stock Option (Right fo Buy) | $5.84 | Feb 10, 2017 | A | 10,000 | A | Feb 10, 2020 | Feb 9, 2027 | Common Stock | 10,000 | 10,000 | D |